查詢結果分析
來源資料
相關文獻
- 潛伏性成人自體免疫糖尿病:第1.5型糖尿病
- 自體抗體與自體免疫疾病
- Correlation between Clinical Activity Score and Thyroid Autoantibodies in Patients with Thyroid Ophthalmopathy
- Significantly Higher Levels of Oxidized LDL Autoantibody in Coronary Artery Disease Patients
- 細小細胞癌併腫瘤相關脊髓炎(Paraneoplastic myelitis)--病例報告
- 氧化型低密度脂蛋白的自體抗體
- Absence of Anti-p53 Autoantibodies in Taiwanese Patients with Type 1 Diabetes Mellitus
- 特發性先天性心傳導完全阻滯併發胎性水腫--病例報告
- Urine Autoantibodies in Interstitial Cystitis: A Preliminary Report
- Autoantibodies and Related Immunity of Leprosy Patients from Leprosarium in Taiwan
頁籤選單縮合
題 名 | 潛伏性成人自體免疫糖尿病:第1.5型糖尿病=Latent Autoimmune Diabetes in Adults: Type 1.5 Diabetes Mellitus |
---|---|
作 者 | 蔡崇煌; 王雪芳; 林綺詩; 鄭正業; 賴淑娥; 王俊堯; | 書刊名 | 臺灣營養學會雜誌 |
卷 期 | 38:1 2013.03[民102.03] |
頁 次 | 頁11-18 |
分類號 | 415.668 |
關鍵詞 | 自體抗體; 麩胺酸脫羧酶自體抗體; 潛伏性兒童自體免疫糖尿病; 潛伏性年輕人自體免疫糖尿病; Autoantibody; GADA; LADA; LADC; LADY; |
語 文 | 中文(Chinese) |
中文摘要 | 過去認為只會出現在第1型糖尿病(T1DM)的自體抗體,約有3.6-13.0%亦會出現在被診斷為第2型糖尿病(T2DM)的病患血液中,此類病患被稱為潛伏性(隱匿性、遲發性)成人自體免疫糖尿病(latent autoimmune diabetes in adults; LADA),有學者稱其為第1.5型糖尿病。典型的LADA病人,最初類似T2DM,可用生活型態控制,但幾個月到數年內即需要口服降血糖藥物及快速進展至類似T1DM完全需依賴施打胰島素,此類患者進展至胰島素依賴,較抗體陰性及肥胖特徵的T2DM患者快很多,最終會至類似T1DM之臨床特徵,如體重減輕、酮症傾向、不穩定的血糖和C-胜肽的減少。目前LADA尚無一個標準化的診斷及治療模式,本文就其與T1DM及T2DM之差異及處置做一探討。 |
英文摘要 | The autoantibodies that only appear in type 1 diabetes mellitus(T1DM) also appear in about 3.6%~13.0% of type 2 diabetes mellitus (T2DM) patients, and this disease is known as latent autoimmune diabetes in adults(LADA) and is also called type 1.5 diabetes mellitus. The progression of autoimmune -cell failure in LADA is slower than that of T2DM; therefore, insulin is not required at least during the first several months after a diagnosis of diabetes, and lifestyle modifications can initially be used to control glucose levels. Unfortunately, oral hypoglycemic agents and insulin are needed after several months to years. Progression of symptoms of T1DM, such as weight loss, a tendency to ketosis, unstable glucose control, and decreased C-peptide, occurs later. There currently are no standard diagnosis or treatment. Differences of LADA with T1DM and T2DM and the management of LADA are discussed. |
本系統中英文摘要資訊取自各篇刊載內容。